0RAG Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Abionyx Pharma SA

Watchlist Manager

Watchlist

Price: 2.05 EUR 6.22% Market Closed

Market Cap: €288.5k

A	Abionyx Pharma SA LSE:0RAG	FR
	Galapagos NV OTC:GLPGF	BE
J	JAFCO Group Co Ltd XBER:JAF	JP

Profitability Summary

Abionyx Pharma SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Sustainable 3Y Average Gross Margin

16%

Gross Margin is Increasing

11% > 13%

Negative Operating Margin

-136%

Negative 3Y Average Operating Margin

-94%

Declining Operating Margin

-82% > -136%

Negative Net Margin

-137%

Negative 3Y Average Net Margin

-94%

Declining Net Margin

-82% > -137%

Negative Free Cash Flow Margin

-78%

Negative 3Y Average Free Cash Flow Margin

-74%

Declining Free Cash Flow Margin

-52% > -78%

Negative ROE

-92%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-46%

Declining ROIC

-35% > -66%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

13%

Sustainable 3Y Average Gross Margin

16%

Gross Margin is Increasing

11% > 13%

Negative Operating Margin

-136%

Negative 3Y Average Operating Margin

-94%

Declining Operating Margin

-82% > -136%